Comments (10) Eli Lillys (LLY) obesity therapy, tirzepatide, can lead to greater weight loss but with a greater loss of lean body mass compared to Novo Nordisks (NVO) rival therapy, semaglutide, according to a new study based on real-world data
Track your progress with a focus on safely What Are GLP-1 Weight Loss Medications
A compound, or a pharmaceutically acceptable salt thereof, as claimed by 14
patients with hypertriglyceridaemia (very high triglycerides) may have an elevated baseline risk Gallbladder disease : GLP-1 receptor agonists are associated with increased risk of gallstones and cholecystitis
Copay assistance programs : Novo Nordisk offers copay assistance programs to reduce the cost of medication for eligible patients, making it more accessible for many
It will be interesting where this type of medication can go to improve the health of our population. With an eye on continued research aimed at sustained long-term benefits, GLP-1 medications may also help in avoiding some health issues altogether
